^
Association details:
| Biomarker: | ERCC1 overexpression |
|---|---|
| Cancer: | Squamous Cell Carcinoma of Head and Neck |
| Drug: | cisplatin (DNA synthesis inhibitor) + 5-fluorouracil (Thymidylate synthase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Predictive biomarkers for combined chemotherapy with 5-fluorouracil and cisplatin in oro- and hypopharyngeal cancers
Published date:
11/29/2017
Excerpt:
Response to induction chemotherapy was significantly correlated with the log-transformed mRNA expression levels of ERCC1 (P=0.0054), XPA (P=0.0154), p53 (P=0.0092), DPD (P=0.0274), Bcl-2 (P=0.0135), VEGF (P=0.0213), and MDR1 (P=0.0389). Interestingly, high expression levels of these genes were significantly associated with increased sensitivity to chemotherapy.
DOI:
10.3892/mco.2017.1521
